CTCatherine Tomko

Catherine Tomko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Catherine Tomko has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Susan G. Sherman

    Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 1812 Ashland Ave., Baltimore, MD, 21205, USA

    14 shared publications
  • Noya Galai

    Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA

    7 shared publications
  • Danielle Friedman Nestadt

    Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, USA

    6 shared publications
  • Susan G. Sherman

    Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    6 shared publications
  • Emily Clouse

    Affiliation Department of Health, Behavior, and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America

    5 shared publications
  • Katherine Haney

    Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA

    5 shared publications

Latest Publications

  • Open Access

    Gentrification, policing, and potential pathways to health: A scoping review

    by Catherine Tomko, Keiana Greene, Hrday Kowdley, Natalie Flath, Abigail Winiker, Brennan Rhodes Bratton, Susan G. Sherman, Roland J. Thorpe, Sabriya Linton, Saba Rouhani

  • Open Access

    A study protocol to explore the effectiveness and implementation of mobile community outreach services for women who use drugs in Baltimore, Maryland: The SHOUT Study

    by Sewika Sulpe, Catherine Tomko, Emily Clouse, Andrea L. Wirtz, Brian Weir, Nouran El-Ashry, Susan G. Sherman

    The opioid overdose crisis has continued to affect women who use drugs (WWUD), particularly in urban cities such as Baltimore, Maryland, where fatal overdose rates rank among the highest in the nation. Despite evidence demonstrating the impact of mobile health services in serving underserved populations, few interventions are specifically tailored to meet the unique needs of WWUD. The Sustained Harm Reduction OUTreach (SHOUT) study evaluates the effectiveness and implementation of a harm reduction–based mobile outreach service operated by a community-based organization serving WWUD in Southwest Baltimore. The “intervention group” consists of WWUD recruited within the organization’s catchment area, while the “control group” comprises those recruited from neighborhoods outside of the organization’s catchment area. The study’s three aims are: (1) to conduct in-depth interviews with WWUD (N=12) to assess the feasibility of using a modified respondent-driven sampling (RDS) method; (2) to conduct a prospective cohort study comparing intervention (N=250) and control (N=150) groups over 18 months to assess nonfatal overdose and healthcare access outcomes; and (3) to evaluate intervention implementation using the RE-AIM framework. The study is guided by Andersen’s Behavioral Model for Vulnerable Populations and Rhodes’s Risk Environment Framework. Preliminary findings suggest that a modified RDS approach is both feasible and acceptable among WWUD. Aim 2 will examine the effect of mobile services on reducing nonfatal overdoses by promoting harm reduction practices within participants’ social and physical environments. Aim 3 will incorporate qualitative and cost-effectiveness analyses to contextualize the program’s impact and sustainability. This study addresses critical service gaps for WWUD by integrating and providing low-barrier harm reduction services offered on an accessible mobile van. Findings will inform scalable, community-driven strategies to reduce overdose mortality and improve health equity among structurally vulnerable populations. Strengths, limitations, and plans for results dissemination are discussed.

  • “I’m Going to Work, but It Is Survival, Too”

    by Mahima Ba Krishnamoorthi, Samantha Grace Alarcon Basurto, Susan Sherman, Catherine Tomko

    Objective: The Surgeon General released the Framework for Mental Health and Well-being in the Workplace, a call to attention for industry leaders. In this study, we applied this framework to street-based women sex workers (WSW) to understand their mental health outcomes. Methods: Fourteen WSW in Baltimore, Maryland, completed structured qualitative interviews to characterize occupational environment in street-based sex work and mental health outcomes. Results: WSW expressed workplace desires shared by those in the traditional workforce, such as flexibility, sense of belonging, safety and security. Factors like violence, lack of a strong support network, and enduring social stigma were highlighted as occupational barriers to positive mental health. Conclusions: This study is the first to use the Surgeon General’s Framework for Mental Health and Well-being in the Workplace to incorporate the perspectives of street-based WSW.

  • Open Access

    Combinations of substances contributing to death among overdose decedents in Maryland (2020–2021)

    by Catherine Tomko, Ju Nyeong Park, Masoumeh Amin-Esmaeili, Kristin Schneider, Ryoko Susukida, Himani Byregowda, Taylor Parnham, Renee M Johnson

    Background In 2020, Maryland had the fourth-highest opioid overdose mortality rate in the USA. We describe substances identified in postmortem toxicology screening and designated as cause of death (COD) for overdose decedents in Maryland, including specific combinations of substances designated as COD. Methods We performed a retrospective analysis of N=5442 adult overdose decedents (ie, manner of death unintentional or undetermined) in Maryland between January 2020 and December 2021. Overdose mortality data from the State Unintentional Drug Overdose Reporting System. Substances were categorised into five major categories: opioids, alcohol, psychostimulants, sedative-hypnotics and psychotropic drugs. Opioids were further divided into prescription opioids (eg, oxycodone, methadone, tramadol) and illicit opioids (eg, illicitly manufactured fentanyl (IMF), heroin). Results Opioids were present in 93% of cases and designated as COD for 92%. IMF was the predominant opioid designated as COD (82% of cases), whereas heroin was COD in only 3%. Psychostimulants, predominantly cocaine, were present in 48% of cases and designated as COD in 41%. Opioids alone were COD in 39% of cases, opioids and psychostimulants in combination were COD for 27%, followed by opioids and alcohol (9%), opioids, alcohol and psychostimulants (6%), and opioids and sedative-hypnotics (4%). Conclusions IMF is, by far, the leading cause of overdose in Maryland. For more than one-quarter of decedents, opioids and psychostimulants in combination were COD. Specific drug combinations have implications for public health surveillance and harm reduction efforts to keep people who use drugs safer from a volatile drug market and potential fatal overdose.

  • Open Access

    Multiple material need insecurities and severity of psychological distress during the COVID-19 pandemic among women who use drugs

    by Catherine Tomko, Laura Nicole Sisson, Katherine Haney, Emily Clouse, Natalie Flath, Noya Galai, Katherine C. Smith, Susan G. Sherman

    Background: The COVID-19 pandemic highlighted the salience of material needs and financial precarity on mental health and distress. Women who use drugs (WWUD) experienced significant mental distress and multiple material need insecurities before the pandemic. However, research is limited on the nature of these insecurities during the pandemic despite both material scarcity and mental distress placing WWUD at greater risk of drug-related harms such as overdose. We aim to characterize material need insecurities and their associations with level of mental distress among a sample of WWUD in the United States during the COVID pandemic. Methods: N = 227 WWUD (i.e., non-medical use of opioids, crack or powdered cocaine at least three times in the past three months) were recruited in Baltimore, Maryland between August 2021-December 2022. We assessed participants’ challenges (i.e., none, minor, major challenge) in accessing five critical material needs during the pandemic: housing; food security; clean, potable water; transportation; and bathroom facilities. The number of major challenges was summed and dichotomized as minimal (0–1) challenges vs. multiple (2+) challenges. The outcome was severity of mental distress, measured by the Kessler-6 and categorized into no/mild, moderate, or severe distress based on validated cut-points. Multinomial logistic regression models were used to explore differences between mental distress severity groups. Results: 36% of the sample reported symptoms of moderate psychological distress and 39% severe distress. Nearly half (43%) reported multiple material need insecurities during COVID. Compared to those who reported minimal material need insecurities, participants with multiple insecurities were 3.25 (95% CI = 1.42–7.45) and 1.96 (95% CI = 0.97–3.95) times more likely to report severe psychological distress compared to no/mild distress or moderate distress, respectively. Unmet mental health needs increased risk of severe distress compared to no/mild 3.44 (95% CI = 1.48–7.97) or moderate 3.62 (95% CI = 1.75–7.49) distress. Conclusions: WWUD experienced a substantial burden of multiple material needs during the pandemic which were associated with elevated levels of mental distress. Results speak to the need to advance mental health equity by addressing access to material needs and mental healthcare for marginalized populations, particularly during health emergencies that threaten already-precarious social safety nets and healthcare infrastructure.


  • Implementation of Overdose Prevention in Maryland: Implications for Resource Allocation, Program Scale-Up, and Evaluation

    by Catherine Tomko, Saba Rouhani, Renee M. Johnson, Ryoko Susukida, Himani Byregowda, Taylor Parnham, Kristin E. Schneider, Marianne Gibson, Teresa Heath, Robin Rickard, et al.

    Overdose mortality in the United States continues to climb, with Maryland being one of the hardest hit states. We summarized implementation of overdose prevention and response programs in Maryland and identified associations between opioid overdose deaths by jurisdiction in 2019 and implementation of overdose programs by 2021. Data on program implementation are from Maryland’s Opioid Operational Command Center (OOCC) Program Inventory. OOCC coordinates the state’s response to overdose, and their Program Inventory tracks implementation of 145 programs across 12 domains (e.g., public health, education, and judiciary), including 10 programs designed to broaden naloxone access. The level of program implementation was dichotomized as substantial implementation versus other levels (i.e., partial, planned, and none). We estimated associations between per capita opioid overdose deaths and substantial implementation of: all 145 programs in the Inventory, programs within each of 12 domains, and 10 naloxone programs. Data on program implementation and overdose mortality are summarized at the jurisdiction level. Across jurisdictions, the median proportion of programs with substantial implementation was 51% across all programs and 70% among naloxone programs. Overdose mortality was associated with subsequent substantial implementation of programs within the public health domain ( p = .04), but not in the other 11 domains. We did not find evidence that per capita overdose deaths in 2019 spurred overdose program implementation by 2021, with the exception of public health programs. The OOCC Program Inventory is a novel way to track implementation across jurisdictions. Findings can inform the implementation and evaluation of overdose programs in other jurisdictions across the United States.

  • Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study

    by Minna Song, Isha K. Desai, Avery Meyer, Hridika Shah, Brendan Saloner, Susan G. Sherman, Sean T. Allen, Catherine Tomko, Kristin E. Schneider, Noa Krawczyk, et al.


  • Severity of Post-traumatic Stress and Non-medical, Concomitant Opioid and Benzodiazepine Use in a Sample of Women at High Risk of Overdose

    by Catherine Tomko, Kristin E. Schneider, Danielle Friedman Nestadt, Jessica L. Zemlak, Susan G. Sherman

    Women who exchange sex and use opioids experience substantial post-traumatic stress disorder (PTSD) symptoms. Among veterans, PTSD increases the risk of concomitant opioid-benzodiazepine use, increasing overdose risk, but this relationship is underexplored in other at-risk populations. We examined correlates of non-medical benzodiazepine use among a cohort of women who exchange sex and use opioids daily (N = 270) in Baltimore, MD. PTSD symptom severity was measured by the full PCL-5 (possible range: 0–80, categorized by tertile as low, medium, high) and four symptom-specific subscales. The prevalence of benzodiazepine use was 27% and the median PCL-5 score was 34. In adjusted models, women with high PCL-5 scores were more likely to use benzodiazepines than those with low scores, overall and across subscales. Severe PTSD symptoms conferred elevated risk of concomitant opioid-benzodiazepine use, calling attention to the importance of addressing trauma in combating the opioid and overdose crises.


  • Open Access

    A study protocol to explore and implement community-based point-of-care COVID-19 testing for women who use drugs in Baltimore, Maryland: The CARE study

    by Catherine Tomko, Emily Clouse, Katherine Haney, Noya Galai, Katherine Footer, Kadija Ferryman, Katherine Clegg Smith, Susan G. Sherman

    Women who use drugs (WWUD) experience structural vulnerabilities (e.g., housing, food insecurities) and comorbidities that elevate their susceptibility to more severe COVID-19 symptoms or fatality compared to similarly-aged women who do not use illicit drugs. Testing is a cornerstone of effective COVID prevention, however, entrenched barriers to healthcare utilization means that WWUD may have diminished accessing to COVID testing. The CARE (COVID Action Research Engagement) study first examines predisposing and enabling factors that predict COVID testing uptake over six months (baseline, 3-, and 6-month follow-up) among a cohort of WWUD (N = 250) in Baltimore, Maryland, providing a nuanced and holistic understanding of how to meaningfully engage WWUD in COVID testing. Then, point-of-care COVID testing will be implemented on a mobile outreach van affiliated with a local community-based organization primarily serving WWUD; anonymous surveys of mobile outreach guests (N = 100) will assess feasibility and acceptability of this integrated testing. The study is grounded in the Behavioral Model for Vulnerable Populations and the Theoretical Framework of Acceptability. We hypothesize that point-of-care COVID testing integrated into a low-barrier harm reduction service, such as a mobile outreach program, will be an enabling environment for COVID testing uptake in part by reducing structural impediments to testing and will be highly feasible and acceptable to participants. Strengths, limitations, and plans for results dissemination are discussed.